Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28639467 | 0.74 | — | — | |
| SCHEMBL2057540 | 0.74 | — | — | |
| SCHEMBL538605 | 0.70 | F2 (0.30) | — | |
| SCHEMBL10586382 | 0.63 | — | — | |
| SCHEMBL10656093 | 0.61 | — | — | |
| SCHEMBL2372343 | 0.58 | — | — | |
| SCHEMBL461524 | 0.58 | — | — | |
| SCHEMBL777164 | 0.58 | — | — | |
| SCHEMBL704367 | 0.56 | — | — | |
| SCHEMBL23819874 | 0.55 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8716435-B2 | Multibranched polyoxyalkylene compound and producing method thereof | NOF CORPORATION (JP) | 2014-05-06 | — | — | US | disclosed |
| EP-2415800-B1 | HYPERBRANCHED POLYOXYALKYLENE COMPOUND AND METHOD FOR PRODUCING SAME | NOF CORP (JP) | 2013-10-16 | — | — | EP | disclosed |
| CN-102378775-B | Multibranched polyoxyalkylene compound and process for producing the same | NIPPON OIL CORP | 2013-10-09 | — | — | CN | disclosed |
| CN-102378775-A | Multibranched polyoxyalkylene compound and process for producing the same | NOF CORP | 2012-03-14 | — | — | CN | disclosed |
| EP-2415800-A1 | HYPERBRANCHED POLYOXYALKYLENE COMPOUND AND METHOD FOR PRODUCING SAME | NOF Corporation (JP) | 2012-02-08 | — | — | EP | disclosed |
| US-20100261863-A1 | MULTIBRANCHED POLYOXYALKYLENE COMPOUND AND PRODUCING METHOD THEREOF | NOF CORPORATION (JP) | 2010-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100261863-A1 | MULTIBRANCHED POLYOXYALKYLENE COMPOUND AND PRODUCING METHOD THEREOF | OPRM1, AOC2, OPRK1 | USP2 218/4885TSHR 4384/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.